Risk Factors for Death in Patients with Severe Acute Pancreatitis in Guizhou Province, China

Table 2

Comparison of laboratory examinations at admission between the survival group and the nonsurvival group in patients with SAP.

Indicators (normal range)	All patients ()	Survivor ()	Nonsurvivor ()
Leukocyte count (/L)	12.88 (6.42)	13.14 (6.43)	11.19 (6.12)	0.02
Neutrophil count (/L)	11.12 (5.75)	11.34 (5.70)	9.72 (5.91)	0.03
Lymphocyte count (/L)	0.92 (0.49)	0.93 (0.49)	0.87 (0.54)	0.39
Platelet count (/L)	158.00 (113.50, 211.00)	163.00 (122.00, 217.00)	116.50 (85.00, 190.00)	0.02
ALT (9-50 U/L)	25.00 (15.00, 54.75)	23.00 (14.00, 50.00)	40.00 (20.00, 148.00)	0.04
AST (15-40 U/L)	42.50 (26.00, 83.75)	40.00 (25.00,70.00)	93.00 (37.50, 283.50)	0.11
Total bilirubin (5-21 μmol/L)	20.00 (13.80, 31.25)	19.50 (13.70, 30.10)	24.80 (16.90, 64.65)	0.01
Creatinine (41-109 μmol/L)	71.00 (54.00, 118.00)	68.00 (52.00, 99.00)	162.00 (78.50, 259.00)	<0.01
Urea nitrogen (2.8-7.2 mmol/L)	5.79 (3.67, 9.54)	5.33 (3.44, 8.61)	10.52 (7.18, 16.90)	0.48
LDH (140-271 U/L)	394.00 (254.50, 587.00)	374.00 (245.00, 539.00)	635.50 (333.50, 1419.75)	0.03
APTT (23.3-32.5 s)	37.20 (30.80, 46.20)	36.25 (30.20, 44.00)	48.10 (36.90, 69.55)	<0.01
TT (14-26 s)	17.10 (15.60, 19.70)	16.90 (15.50, 19.20)	18.80 (16.05, 28.10)	0.06
PTA (70-150%)	95.60 (77.90, 110.00)	97.00 (80.88, 111.50)	77.10 (49.40, 96.90)	<0.01
hs-CRP (0.068-8.200 mg/L)	129.56 (59.81)	130.02 (59.95)	126.65 (59.23)	0.68

SAP: severe acute pancreatitis; ALT: alanine aminotransferase; AST: aspartate transaminase; LDH: lactic dehydrogenase; APTT: activated partial thromboplastin time; TT: thrombin time; PTA: prothrombin time activity; CRP: C-reactive protein.